MMJ.com
Hybrid (Sativa-leaning)

Blue Dream | Cannabis Strain Review & Effects

Also known as: Blueberry Dream, Azure Haze

Blueberry x Haze

Blue Dream is a hybrid-leaning sativa strain (Blueberry x Haze) with THC levels of 17-24%. It features a Myrcene-dominant terpene profile and is known for relaxation and euphoria. Best used during the afternoon.

THC

17-24%

CBD

0.1-2%

Best Time

Afternoon

Primary Effects

RelaxationEuphoriaCreativityPain Relief

Flavor Notes

Sweet berry, Blueberry, Herbal, Vanilla

Aroma

Sweet blueberry and fresh berries with subtle herbal undertones

Research Sources

29 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

December 2025

Every claim cites peer-reviewed research
How We Research

What is Blue Dream?

Blue Dream is a hybrid-leaning sativa strain (Blueberry x Haze) with THC levels of 17-24%. It features a Myrcene-dominant terpene profile and is known for relaxation and euphoria. Best used during the afternoon.

About Blue Dream Strain

Blue Dream is one of the most popular strains in the United States, known for its balanced effects that combine full-body relaxation with gentle cerebral invigoration. The high myrcene content contributes to its relaxing properties, while pinene may help maintain mental clarity. Its versatile effects make it suitable for both novice and experienced users.

Related Reading

Understanding Myrcene

Learn about this terpene

Browse All Strains

Compare Hybrid (Sativa-leaning) strains

Get Your MMJ Card

Access medical cannabis legally

Terpene Profile

Myrcenedominant
Earthy, musky, clove-like~0.85%

Primary research: Sedation & Relaxation

Pineneprimary
Fresh pine, forest, evergreen~0.45%

Primary research: Mental Clarity

Beta-Caryophyllenesecondary
Spicy, peppery, woody, clove-like~0.25%

Primary research: Anti-inflammatory

Concentration Levels

Dominant (>1.0%)
Primary (0.5-1.0%)
Secondary (0.1-0.5%)
Trace (<0.1%)

Cannabinoid Profile

THCPsychoactive

17-24%

Pain Relief

CBD

0.1-2%

Seizure Reduction

Therapeutic Profile Matches

Based on Blue Dream's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:

migraines

63%
Moderate Match
  • High myrcene content supports migraines & headaches
  • thc dominant ratio matches profile
  • Best used afternoon, aligning with condition needs

chronic pain

60%
Moderate Match
  • High myrcene content supports chronic pain
  • Best used afternoon, aligning with condition needs

multiple sclerosis

56%
Moderate Match
  • High myrcene content supports multiple sclerosis
  • Best used afternoon, aligning with condition needs

muscle spasms

55%
Moderate Match
  • High myrcene content supports muscle spasms & spasticity
  • High beta-caryophyllene content supports muscle spasms & spasticity

epilepsy

53%
Moderate Match
  • High beta-caryophyllene content supports epilepsy & seizures
  • Best used afternoon, aligning with condition needs

Match scores are theoretical

These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.

  1. 1

    Surendran S, et al. Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021

    Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.

    PubMed: 34368215View Source
  2. 2

    Sewell RA, et al. The Effects of β-myrcene on Simulated Driving Cannabis and Cannabinoid Research. 2023

    Found myrcene alone did not significantly impair simulated driving performance.

    PubMed: 37126442View Source
  3. 3

    do Vale TG, et al. Sedative effects of myrcene in mice Phytomedicine. 2002

    Demonstrated dose-dependent sedative and motor-relaxant effects in mice.

    PubMed: 12587690View Source
  4. 4

    Lorenzetti BB, et al. Anti-inflammatory activity of myrcene Journal of Ethnopharmacology. 1991

    Found peripheral analgesic activity in animal models.

    PubMed: 1753786View Source
  5. 5

    Rao VS, et al. Antinociceptive action of myrcene Journal of Pharmacy and Pharmacology. 1990

    Investigated pain-modulating mechanisms in animal studies.

    PubMed: 1983142View Source
  6. 6

    Lee GY, et al. Alpha-pinene enhances memory via acetylcholinesterase inhibition Dementia and Geriatric Cognitive Disorders. 2017

    α-Pinene inhibited AChE and improved memory in mice.

    PubMed: 28359064View Source
  7. 7

    Falk AA, et al. Bronchodilator effects of α-pinene Xenobiotica. 1990

    α-Pinene showed bronchodilator activity in humans.

    PubMed: 2238697View Source
  8. 8

    Nam SY, et al. Anti-inflammatory and anti-allergic activities of α-pinene Phytotherapy Research. 2014

    α-Pinene reduced IgE-mediated allergic inflammation.

    PubMed: 24227599View Source
  9. 9

    Salehi B, et al. Biological activities of α-pinene: A comprehensive review Biomolecules. 2019

    Most comprehensive review of pinene pharmacology.

    PubMed: 31443395View Source
  10. 10

    Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008

    Landmark paper: BCP directly activates CB2 receptors.

    PubMed: 18574142View Source
  11. 11

    Klauke AL, et al. β-Caryophyllene reduces neuropathic pain via CB2 and PPAR-γ European Journal of Pain. 2014

    Showed dual mechanism for neuropathic pain relief.

    PubMed: 24338862View Source
  12. 12

    Bahi A, et al. Anxiolytic-like effect of β-caryophyllene Physiology & Behavior. 2014

    BCP reduced anxiety via CB2 receptor activation.

    PubMed: 24582908View Source
  13. 13

    Horvath B, et al. Anti-inflammatory effects of β-caryophyllene Free Radical Biology and Medicine. 2012

    BCP reduced inflammation markers and oxidative stress.

    PubMed: 22569421View Source
  14. 14

    Tambe Y, et al. Gastroprotective effects of β-caryophyllene Planta Medica. 1996

    BCP protected gastric mucosa in ulcer models.

    PubMed: 8923806View Source
  15. 15

    Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046

    Landmark paper first identifying and synthesizing THC.

    DOIView Source
  16. 16

    Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015

    Comprehensive review finding moderate evidence for chronic pain.

    PubMed: 26103030View Source
  17. 17

    Aviram J, Samuelly-Leichtag G. Cannabinoids for neuropathic pain Journal of Pain Research. 2017

    Review of clinical trials for neuropathic pain.

    PubMed: 28860855View Source
  18. 18

    Lutge EE, et al. Dronabinol for AIDS-related anorexia Cochrane Database of Systematic Reviews. 2013

    Systematic review of appetite stimulation evidence.

    PubMed: 23539665View Source
  19. 19

    Smith LA, et al. Cannabinoids for chemotherapy-induced nausea and vomiting Cochrane Database of Systematic Reviews. 2015

    High-quality evidence for CINV efficacy.

    PubMed: 26561338View Source
  20. 20

    Kesner AJ, Lovinger DM. Cannabis, cannabinoids, and sleep Neuropsychopharmacology. 2020

    Review of THC effects on sleep architecture.

    PubMed: 31767987View Source
  21. 21

    Novotna A, et al. Nabiximols for spasticity in multiple sclerosis European Journal of Neurology. 2011

    Phase III trial showing efficacy for MS spasticity.

    PubMed: 21696543View Source
  22. 22

    Silvestro S, et al. Therapeutic potential of cannabidiol (CBD) Journal of Cellular Physiology. 2020

    Comprehensive review of CBD's therapeutic applications.

    PubMed: 31960376View Source
  23. 23

    Devinsky O, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome New England Journal of Medicine. 2018

    Phase III trial leading to FDA approval of Epidiolex.

    PubMed: 29768152View Source
  24. 24

    Devinsky O, et al. Cannabidiol for treatment-resistant epilepsy Lancet Neurology. 2016

    Open-label trial showing 36.5% reduction in seizures.

    PubMed: 26724101View Source
  25. 25

    Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019

    79.2% of patients reported reduced anxiety within first month.

    PubMed: 30624194View Source
  26. 26

    Bergamaschi MM, et al. CBD reduces anxiety in social anxiety disorder Neuropsychopharmacology. 2011

    CBD reduced anxiety in simulated public speaking test.

    PubMed: 21307846View Source
  27. 27

    Burstein S. Cannabidiol as an emergent therapeutic strategy for reducing inflammation Bioorganic & Medicinal Chemistry. 2015

    Review of CBD's anti-inflammatory mechanisms.

    PubMed: 25997150View Source
  28. 28

    Shannon S, et al. Cannabidiol for treatment of insomnia Permanente Journal. 2019

    66.7% of patients reported improved sleep.

    PubMed: 30624194View Source
  29. 29

    Boyaji S, et al. Cannabidiol for chronic pain management Current Opinion in Anesthesiology. 2020

    Review of CBD's analgesic mechanisms.

    PubMed: 32740152View Source

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

What are the effects of Blue Dream?

Blue Dream provides balanced effects combining relaxation with gentle mental stimulation. Users commonly report feeling relaxed, euphoric, and creative. Its myrcene-dominant profile promotes calm while pinene may support focus.

Is Blue Dream good for beginners?

Yes, Blue Dream is often recommended for beginners due to its balanced, manageable effects. The high is typically described as gentle and approachable, with less chance of anxiety compared to more potent strains.

What does Blue Dream taste like?

Blue Dream has a sweet, berry-like flavor with prominent blueberry notes inherited from its Blueberry parent. Many users also detect subtle vanilla and herbal undertones.

Quick Facts

Type
Hybrid (Sativa-leaning)
Genetics
Blueberry x Haze
Breeder
DJ Short (Blueberry lineage)
Genetic Family
Blueberry Family
Best Time of Use
Afternoon
Availability
common
Grow Difficulty
moderate

Dominant Terpene

Myrcene

Earthy, musky, clove-like

Want to try Blue Dream? Get your medical marijuana card today.

Get Your Card

Related by Genetics

Granddaddy Purple

indica

Harlequin

sativa

Pineapple Express

hybrid sativa

Educational Information

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Strain Variability

Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.

Beyond Indica/Sativa

Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.

Understanding Therapeutic Profiles

Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.

Learn About Therapeutic Profiles